The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study.
Hao-Ran ZhengAi-Min JiangHuan GaoNa LiuXiao-Qiang ZhengXiao FuRui ZhangZhi-Ping RuanTao TianXuan LiangYu YaoPublished in: Cancer management and research (2022)
Anlotinib is effective and well tolerated in patients with ES-SCLC in the real-world. The clinical efficacy of anlotinib combined with chemotherapy or immunotherapy is better than that of monotherapy. Further investigations are needed for prospective studies with larger sample size.